These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1403 related articles for article (PubMed ID: 20841605)

  • 41. Long-term prediction by DNA methylation of high-grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort.
    Gilham C; Nedjai B; Scibior-Bentkowska D; Reuter C; Banwait R; Brentnall AR; Cuzick J; Peto J; Lorincz AT
    Int J Cancer; 2024 Jul; 155(1):81-92. PubMed ID: 38507581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
    Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
    Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe.
    Tjalma WA; Fiander A; Reich O; Powell N; Nowakowski AM; Kirschner B; Koiss R; O'Leary J; Joura EA; Rosenlund M; Colau B; Schledermann D; Kukk K; Damaskou V; Repanti M; Vladareanu R; Kolomiets L; Savicheva A; Shipitsyna E; Ordi J; Molijn A; Quint W; Raillard A; Rosillon D; De Souza SC; Jenkins D; Holl K;
    Int J Cancer; 2013 Feb; 132(4):854-67. PubMed ID: 22752992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
    Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Forslund O; Hansson BG; Hagmar B; Johansson B; Rylander E; Dillner J
    J Natl Cancer Inst; 2009 Jan; 101(2):88-99. PubMed ID: 19141778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort.
    Peto J; Gilham C; Deacon J; Taylor C; Evans C; Binns W; Haywood M; Elanko N; Coleman D; Yule R; Desai M
    Br J Cancer; 2004 Aug; 91(5):942-53. PubMed ID: 15292939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stratifying HPV-positive women for CIN3+ risk after one and two rounds of HPV-based screening.
    Veldhuijzen NJ; Polman NJ; Snijders PJF; Meijer CJLM; Berkhof J
    Int J Cancer; 2017 Oct; 141(8):1551-1560. PubMed ID: 28670823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
    J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.
    Wheeler CM; Hunt WC; Joste NE; Key CR; Quint WG; Castle PE
    J Natl Cancer Inst; 2009 Apr; 101(7):475-87. PubMed ID: 19318628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.
    Stoler MH; Wright TC; Parvu V; Yanson K; Cooper CK; Andrews J
    Gynecol Oncol; 2019 Apr; 153(1):26-33. PubMed ID: 30638767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distribution and diagnostic value of single and multiple high-risk HPV infections in detection of cervical intraepithelial neoplasia: A retrospective multicenter study in China.
    Ye Z; Zhao Y; Chen M; Lu Q; Wang J; Cui X; Wang H; Xue P; Jiang Y
    J Med Virol; 2024 Aug; 96(8):e29835. PubMed ID: 39087721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy.
    Carozzi FM; Tornesello ML; Burroni E; Loquercio G; Carillo G; Angeloni C; Scalisi A; Macis R; Chini F; Buonaguro FM; Giorgi Rossi P;
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2389-400. PubMed ID: 20826836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
    Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
    [No Abstract]   [Full Text] [Related]  

  • 53. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.
    Castle PE; Schiffman M; Wheeler CM; Wentzensen N; Gravitt PE
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1675-81. PubMed ID: 20615885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Co-infection with trichomonas vaginalis increases the risk of cervical intraepithelial neoplasia grade 2-3 among HPV16 positive female: a large population-based study.
    Yang M; Li L; Jiang C; Qin X; Zhou M; Mao X; Xing H
    BMC Infect Dis; 2020 Sep; 20(1):642. PubMed ID: 32873233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
    Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.
    Mariano VS; Lorenzi AT; Scapulatempo-Neto C; Stein MD; Resende JC; Antoniazzi M; Villa LL; Levi JE; Longatto-Filho A; Fregnani JH
    PLoS One; 2016; 11(10):e0164892. PubMed ID: 27764154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HPV-genotypes in high-grade intraepithelial cervical lesions in Danish women.
    Kirschner B; Schledermann D; Holl K; Rosenlund M; Raillard A; Quint W; Molijn A; Jenkins D; Junge J
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1032-40. PubMed ID: 23647074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus.
    Cox JT
    Baillieres Clin Obstet Gynaecol; 1995 Mar; 9(1):1-37. PubMed ID: 7600720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
    Thomsen LT; Kjaer SK; Munk C; Ørnskov D; Waldstrøm M
    Acta Obstet Gynecol Scand; 2021 Mar; 100(3):394-402. PubMed ID: 33566361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Performance of APTIMA Human Papillomavirus (HPV) 16 18/45 mRNA Genotyping Testing for the Detection of Cervical Intraepithelial Neoplasia 3 (CIN3) or Cancer in a Select Group of Chinese Women.
    Guo YL; You K; Geng L; Qiao J
    Pathol Oncol Res; 2016 Jul; 22(3):549-54. PubMed ID: 26710763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 71.